Showing results 1 to 20 of 56
next >
| Issue Date | Title | Author(s) |
| 2022-06 | Timothy Grass Pollen Induces Spatial Reorganisation of F-Actin and Loss of Junctional Integrity in Respiratory Cells. | Bradbury, P; Cidem, A; Mahmodi, H; Davies, JM; Spicer, PT; Prescott, SW; Kabakova, I; Ong, HX; Traini, D |
| 2022-04-02 | Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development. | Gholizadeh, H; Cheng, S; Kourmatzis, A; Xing, H; Traini, D; Young, PM; Ong, HX |
| 2022-02-22 | Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract. | Zhang, Y; Almazi, JG; Ong, HX; Johansen, MD; Ledger, S; Traini, D; Hansbro, PM; Kelleher, AD; Ahlenstiel, CL |
| 2021-08-05 | How Do Mechanics Guide Fibroblast Activity? Complex Disruptions during Emphysema Shape Cellular Responses and Limit Research. | Leslie, MN; Chou, J; Young, PM; Traini, D; Bradbury, P; Ong, HX |
| 2021-07-05 | Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line. | Sheikh, Z; Bradbury, P; Reekie, TA; Pozzoli, M; Robinson, PD; Kassiou, M; Young, PM; Ong, HX; Traini, D |
| 2021-06 | Real-time quantitative monitoring of in vitro nasal drug delivery by a nasal epithelial mucosa-on-a-chip model. | Gholizadeh, H; Ong, HX; Bradbury, P; Kourmatzis, A; Traini, D; Young, P; Li, M; Cheng, S |
| 2021-03-01 | Development and in vitro characterization of a novel pMDI diclofenac formulation as an inhalable anti-inflammatory therapy for cystic fibrosis. | Sheikh, Z; Gomes Dos Reis, L; Bradbury, P; Meneguzzo, G; Scalia, S; Young, PM; Ong, HX; Traini, D |
| 2020-11 | An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line. | Sheikh, Z; Bradbury, P; Pozzoli, M; Young, PM; Ong, HX; Traini, D |
| 2020-08-21 | Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of size. | Landh, E; M Moir, L; Bradbury, P; Traini, D; M Young, P; Ong, HX |
| 2020-04 | Effect of continuous positive airway pressure treatment on permeability, inflammation and mucus production of human epithelial cells. | Grau-Bartual, S; Al-Jumaily, AM; Young, PM; Traini, D; Ghadiri, M |
| 2020-01 | Modifying and Integrating <i>in vitro</i> and <i>ex vivo</i> Respiratory Models for Inhalation Drug Screening. | Cidem, A; Bradbury, P; Traini, D; Ong, HX |
| 2018-10-01 | A Simple and Rapid Method for Deposition and Measurement of Drug Transport Across Air Interface Respiratory Epithelia | Haghi, M; Young, PM; Traini, D |
| 2018-08-25 | Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery | Silva, DM; Paleco, R; Traini, D; Sencadas, V |
| 2018-08-01 | Repurposing of statins via inhalation to treat lung inflammatory conditions | Bradbury, P; Traini, D; Ammit, AJ; Young, PM; Ong, HX |
| 2017-09-02 | Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery | Pozzoli, M; Traini, D; Young, PM; Sukkar, MB; Sonvico, F |
| 2017-04-21 | The effect of non-specific tight junction modulators on the transepithelial transport of poorly permeable drugs across airway epithelial cells | Ghadiri, M; Young, PM; Jarolimek, W; Grau, GER; Oliver, BGG; Traini, D |
| 2016-11-16 | Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study | Martignoni, I; Trotta, V; Lee, WH; Loo, CY; Pozzoli, M; Young, PM; Scalia, S; Traini, D |
| 2016-10-02 | Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation | Pozzoli, M; Rogueda, P; Zhu, B; Smith, T; Young, PM; Traini, D; Sonvico, F |
| 2016-10-01 | Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products | Pozzoli, M; Ong, HX; Morgan, L; Sukkar, M; Traini, D; Young, PM; Sonvico, F |
| 2016-03-30 | Combination of Silver Nanoparticles and Curcumin Nanoparticles for Enhanced Anti-biofilm Activities | Loo, CY; Rohanizadeh, R; Young, PM; Traini, D; Cavaliere, R; Whitchurch, CB; Lee, WH |
